Flu News and Research

RSS

The role of S-acylation in the enhancement of SARS-CoV-2 infectivity

A new study published on the bioRxiv server focuses on the role of S-acylation in the SARS-CoV-2 infection cycle. It has also characterized Spike acylation and has also identified other acylated viral proteins and host enzymes involved in the process of infection. Further, it has also revealed the importance of acylation in viral biogenesis and infection.

18 Mar 2021

Could visible light be a safe and effective SARS-CoV-2 disinfectant?

A new study reports that blue light with a wavelength of 400–420 nm can inactivate enveloped viruses like SARS-CoV-2 and influenza. This could allow continuous disinfection of spaces even when people are present.

17 Mar 2021

COVID-19 is more difficult to diagnose in children and adolescents, finds study

The ongoing pandemic of coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread to over 192 countries and territories, causing an enormous loss of lives and economic devastation.

17 Mar 2021

Researchers develop innovative profiling methods for SARS-CoV-2 infection

A team of researchers from various institutions in the USA used RNA-sequencing data and other methods to profile unique genes and other characteristics associated with SARS-CoV-2 in New York City (NYC).

17 Mar 2021

Covid cases plummet 83% among nursing home staffers despite vaccine hesitancy

Joan Phillips, a certified nursing assistant in a Florida nursing home, loved her job but dreaded the danger of going to work in the pandemic. When vaccines became available in December, she jumped at the chance to get one.

15 Mar 2021

New vaccination method aims at comprehensive protection against all known influenza mutations

One shot, protected forever: This would be a dream come true regarding influenza vaccinations. So far, vaccination against influenza did not provide a lasting protection.

13 Mar 2021

To extract more doses per vial, vaccinators put squeeze on FDA to relax vaccine handling advice

President Joe Biden has promised enough covid vaccine to immunize every willing adult by June 1. But right now, the gap between supply and demand is so dramatic that vaccinators are discovering ways to suck the final drops out of each vaccine vial — if federal regulators will let them.

12 Mar 2021

Tailored approach is required to fight antibiotic resistance

The global battle against antibiotic resistance can only succeed if local contexts are taken into account. "A tailored approach is needed in each country," says Heiman Wertheim of Radboud university medical center. "There is no "one-size-fits-all' solution."

12 Mar 2021

Texas Biomed receives DoD subcontracts to assess SARS-CoV-2 decontamination technologies

Texas Biomedical Research Institute received two Department of Defense's (DoD) Defense Health Agency subcontracts to assess the efficacy of surface coating and aerosolized decontamination technologies to combat SARS-CoV-2 and other respiratory pathogens on surfaces and in the air.

11 Mar 2021

Promega launches XpressAmp™ Direct Amplification Reagents

Promega Corporation has released XpressAmp™ Direct Amplification Reagents that facilitate RNA extraction-free sample preparation that is automation-friendly.

From Promega Corporation 11 Mar 2021

Delaying second doses of COVID-19 vaccines has benefits, but longer-term results rely on robust immunity

Delaying second doses of COVID-19 vaccines should reduce case numbers in the near term.

10 Mar 2021

Researchers discover new COVID-19 variants in three South African provinces

Variants of the coronavirus are appearing in different parts of the world, many of them spreading with alarming speed.

10 Mar 2021

SARS-CoV-2 proteins are potent suppressors of innate immunity

A new study describes the strong immune-suppressing activity of SARS-CoV-2 genes, among other coronavirus genes.

5 Mar 2021

New mRNA treatment appears to stop replication of flu and Covid-19 viruses

With a relatively minor genetic change, a new treatment developed by researchers at the Georgia Institute of Technology and Emory University appears to stop replication of both flu viruses and the virus that causes Covid-19.

4 Mar 2021

Vaccine candidate shows promise to protect against dozen-plus flu strains

Ask Eric Weaver about pandemics, and he's quick to remind you of a fact that illustrates the fleeting nature of human memory and the proximal nature of human attention: The first pandemic of the 21st century struck not in 2019, but 2009.

3 Mar 2021

Obesity may reduce COVID-19 vaccine efficacy, say researchers

A startling indicates that obesity may reduce the immune response to the current COVID-19 vaccines, along with other factors like age and sex. This could have significant implications for vaccination strategies in obese people.

3 Mar 2021

Semaglutide drug also helps diabetic patients lose body weight, shows study

A drug approved for diabetes has now been shown to also help patients with diabetes lose on average 10 percent of their body weight, UT Southwestern reports in a landmark international study.

3 Mar 2021

New computer algorithm offers a path toward pan-influenza and coronavirus vaccine

A novel computer algorithm that could create a broadly reactive influenza vaccine for swine flu also offers a path toward a pan-influenza vaccine and possibly a pan-coronavirus vaccine as well, according to a new paper published in Nature Communications.

2 Mar 2021

Disruption of lung biological clock may explain flu risk in adults who survived premature birth

Disruptions in the circadian rhythms in lung cells may explain why adults who survived premature birth are often more at risk of severe influenza infections, suggests a study in mice published today in eLife.

2 Mar 2021

Study: Public attitude toward COVID-19 and its treatments is more “infectious” than disease itself

Public attitude toward COVID-19 and its treatments is more "infectious" than the disease itself, according to a new Northwestern Medicine study using Artificial Intelligence (AI) to analyze tweets about the virus.

2 Mar 2021

Flu News and Research

The role of S-acylation in the enhancement of SARS-CoV-2 infectivity

Could visible light be a safe and effective SARS-CoV-2 disinfectant?

COVID-19 is more difficult to diagnose in children and adolescents, finds study

Researchers develop innovative profiling methods for SARS-CoV-2 infection

Covid cases plummet 83% among nursing home staffers despite vaccine hesitancy

New vaccination method aims at comprehensive protection against all known influenza mutations

To extract more doses per vial, vaccinators put squeeze on FDA to relax vaccine handling advice

Tailored approach is required to fight antibiotic resistance

Texas Biomed receives DoD subcontracts to assess SARS-CoV-2 decontamination technologies

Promega launches XpressAmp™ Direct Amplification Reagents

Delaying second doses of COVID-19 vaccines has benefits, but longer-term results rely on robust immunity

Researchers discover new COVID-19 variants in three South African provinces

SARS-CoV-2 proteins are potent suppressors of innate immunity

New mRNA treatment appears to stop replication of flu and Covid-19 viruses

Vaccine candidate shows promise to protect against dozen-plus flu strains

Obesity may reduce COVID-19 vaccine efficacy, say researchers

Semaglutide drug also helps diabetic patients lose body weight, shows study

New computer algorithm offers a path toward pan-influenza and coronavirus vaccine

Disruption of lung biological clock may explain flu risk in adults who survived premature birth

Study: Public attitude toward COVID-19 and its treatments is more “infectious” than disease itself

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News